Updated
Updated · Bloomberg · Jun 3
Inotiv Files for Bankruptcy as China Primate Tariffs and US Rules Squeeze Lab-Animal Breeder
Updated
Updated · Bloomberg · Jun 3

Inotiv Files for Bankruptcy as China Primate Tariffs and US Rules Squeeze Lab-Animal Breeder

1 articles · Updated · Bloomberg · Jun 3

Summary

  • Inotiv sought bankruptcy protection after mounting pressure on its business breeding dogs and importing monkeys for drug experiments.
  • US restrictions on the company’s canine farm and tariffs on non-human primates raised in China helped drive the filing, according to a court declaration by CFO Beth Taylor.
  • International competition and a broader US push to reduce animal use in preclinical drug-safety studies further weakened demand and finances.
  • The collapse highlights how regulatory tightening and shifts in drug-testing practices are straining specialized lab-animal suppliers.

Insights

With a key animal supplier bankrupt, is the era of animal testing for new drugs officially ending?
As a major lab animal supplier goes bankrupt, who is responsible for the thousands of animals left behind?
Can new 'organ-on-a-chip' tech replace animal testing without putting human patients at risk?